Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline and Roflumilast for Corticosteroid Efficacy in COPD
NCT02340520Phase 3Completed
- Sponsor
- UConn Health
- Start
- Dec 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of theophylline, roflumilast in chronic obstructive pulmonary disease (COPD), sponsored by UConn Health. Started Dec 2014; status: completed.
02
Drugs
theophyllineroflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02340520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02340520.